Gerardo TurcattiSenior scientific level (R&D) with extensive experience in the management of multidisciplinary technological projects. Prof. Gerardo Turcatti, directs the academic technological platform, Biomolecular Screening Facility (BSF) at the EPFL he created in 2006. In the framework of the NCCR-Chemical Biology, he is project leader of the program ACCESS (An Academic Chemical Screening Platform for Switzerland). Previously he co-founded and acted as CTO of Manteia S.A., a Swiss-based company that developed high throughput DNA sequencing technologies currently owned by Illumina and used in the ‘Next Generation Sequencing’ instruments. Prior to this experience, Prof. Turcatti had a long multidisciplinary career in R&D divisions of Biotechnology and Pharmaceutical companies with extensive expertise in several Chemical Biology-related disciplines such as Drug Screening, Chemical Biology, Bio-analytical Chemistry, DNA and Protein Chemistry. Prof. Turcatti earned his Master in Chemical Engineering at the University of Geneva and his PhD in Chemistry and Biochemistry from the EPFL where he received the award for the best doctoral thesis of the year.
Marilyne AndersenMarilyne Andersen est professeure ordinaire en technologies durables de la construction et dirige le Laboratoire Performance Intégrée au Design (LIPID) qu'elle a fondé en automne 2010. Elle a été Doyenne de la Faculté de l'Environnement Naturel, Architectural et Construit (ENAC) de l'EPFL de 2013 à 2018 et est la Directrice Académique du Smart Living Lab à Fribourg. Elle co-dirige également le Student Kreativity and Innovation Laboratory (SKIL) à l'ENAC.Avant de rejoindre l'EPFL, elle était professeure assistante puis associée (tenure-track) dans le Building Technology Group du MIT, au sein du Département d'Architecture, où elle a fondé et dirigé le MIT Daylighting Lab depuis 2004. Elle a aussi été professeure invitée à la Singapore University of Technology and Design en 2019. Marilyne Andersen détient un Master ès sciences en physique et s'est spécialisée dans l'éclairage naturel durant sa thèse dans la physique du bâtiment à l'EPFL au Laboratoire d'énergie solaire et de physique du bâtiment (LESO) ainsi qu'en tant que chercheuse invitée au Building Technologies Department du Lawrence Berkeley National Laboratory en Californie. Ses recherches se situent à l'interface entre sciences, ingénierie et architecture avec une attention spécifique sur l'impact de la lumière naturelle sur les occupants d'un bâtiment. Avec un focus sur les questions de confort, de perception et de santé et leurs implications énergétiques, ces efforts de recherche visent à une intégration plus profonde de la performance lumineuse et du confort intérieur dans le processus de conception, grâce à de nouvelles synergies avec d'autres domaines scientifiques, comme la chronobiologie et les neurosciences ainsi que la psychophysique ou l'informatique et l'imagerie digitale. Elle s'appuie sur ces recherches pour les étendre à la pratique architecturale à travers la startup OCULIGHT dynamics qu'elle a co-fondée, et qui offre des services spécialisés en éclairage naturel avec un accent particulier sur les effets psycho-physiologiques de la lumière naturelle sur les occupants d'un bâtiment. Elle est l'auteure de plus de 200 articles référés publiés dans des revues scientifiques et lors de conférences internationales, ainsi que la lauréate de plusieurs bourses et prix dont: le Daylight Award for Research (2016), onze prix et distinctions pour ses publications (2009, 2011, 2012, 2015, 2018, 2019, 2021) dont le Taylor Technical Talent Award 2009 décerné par la Illuminating Engineering Society, le 3M Non-Tenured Faculty Award (2009), le Mitsui Career Development Professorship au MIT (2008) et le prix EPFL de la Fondation Chorafas en durabilité attribué pour sa thèse (2005). Ses travaux de recherche ou d'enseignement ont été soutenus par des organisations professionnelles, institutionnelles et industrielles tels que les Fonds National pour la Recherche Scientifique (en Suisse et aux USA), la fondation Velux, le programme Européen Horizon 2020, la Boston Society of Architects, la MIT Energy Initiative et InnoSuisse. Elle a été la directrice et responsable académique de l'équipe suisse et son projet NeighborHub, qui a gagné la compétition U.S. Solar Decathlon 2017 avec 8 podiums sur 10 épreuves. Elle est membre du Conseil de la Fondation LafargeHolcim pour la construction durable et dirige son Comité Académique. Elle est également membre du conseil éditorial de la revue scientifique Building and Environment chez Elsevier ainsi que des revues LEUKOS (de la Illuminating Engineering Society) et Buildings and Cities chez Taylor et Francis. Elle est Experte pour le Conseil d'Innovation InnoSuisse ainsi que membre fondatrice et membre du Conseil de la Fondation Culture du Bâti (CUB). Elle est aussi membre fondatrice de la Daylight Academy et membre active de plusieurs comités de l'Illuminating Engineering Society (IES) et de la Commission Internationale de l'Eclairage (CIE).
Jean-Jacques MeisterCitoyen suisse, Jean-Jacques Meister est né en 1950. Il est titulaire d'un diplôme d'ingénieur en électronique et d'un diplôme d'ingénieur physicien, obtenu en 1979 à l'Ecole polytechnique fédérale de Lausanne (EPFL). Il poursuit sa formation à l'Institut des techniques biomédicales de l'Ecole Polytechnique Fédérale de Zurich et obtient son doctorat ès sciences en 1983. De 1984 à 1990, il travaille dans différents domaines de la physique biomédicale. Ses principales réalisations portent sur le développement de méthodes non-invasives utiles à la prévention et au diagnostic des maladies cardio-vasculaires: caractérisation des propriétés biomécaniques des artères, hémodynamique cardio-vasculaire, échographie Doppler ultrasonore. En 1990, il est nommé professeur de physique expérimentale à l'EPFL où il dirige le Laboratoire de génie médical jusqu'en 2001, puis le laboratoire de biophysique cellulaire. Ses activités de recherche concernent principalement la biophysique cellulaire: dynamique du cytosquelette, motilité & adhésion cellulaire et dynamique du calcium dans les muscles lisses. Lors d'un congé sabbatique en 2000, il complète sa formation en biologie moléculaire et cellulaire au célèbre Marine Biological Laboratory de Woods Hole, dans le Massachusetts, USA. Il enseigne la physique générale, la mécanique générale, le génie biomédical et la biophysique aux étudiants de diverses sections de l'EPFL. Il est auteur ou coauteur de plus de 230 publications scientifiques et chapitres de livres et titulaire de 8 brevets internationaux
Cathrin BriskenCathrin Brisken, MD, PhD, is Associate Professor of Life Sciences at the Swiss Federal Institute of Technology Lausanne (EPFL). Dr. Brisken is internationally recognized for her work on endocrine control of mammary gland development and breast carcinogenesis.
Dr. Brisken received her MD and her PhD degree in Biophysics from the Georg August University of Göttingen, Germany. She completed her postdoctoral work in cancer biology with Dr. R.A. Weinberg at the Whitehead Institute of Biomedical Research in Cambridge, MA, USA. She previously held appointments at the Cancer Center of the Massachusetts General Hospital, Harvard Medical School, Boston and the Swiss Institute for Experimental Cancer Research (ISREC).
Research in Dr. Brisken’s laboratory focuses on the cellular and molecular underpinnings of estrogen and progesterone receptor signaling in the breast and the respective roles of these hormones and hormonally active compounds in carcinogenesis. The aim is to understand how recurrent exposures to endogenous and exogenous hormones contribute to breast carcinogenesis in order to better prevent and treat the disease. The laboratory has pioneered in vivo approaches to genetically dissect the role of the reproductive hormones in driving mouse mammary gland development and shown how they control intercellular communication. Dr. Brisken’s group has developed ex vivo and humanized mouse models using patient samples to study hormone action in human tissues in normal settings and during disease progression.
Dr. Brisken is member of the International Breast Cancer Study Group (IBCSG) Biological Protocol Working Group. She served as Dean of EPFL Doctoral School (more than 2000 PhD students in 18 PhD programs), as member of the Hinterzartener Kreis, the oncology think-tank associated with the German Science Foundation, and numerous Swiss, European, and AACR committees. She co-founded the International Cancer Prevention Institute.
Lukas KühnLukas Kühn graduated in biochemistry at the Swiss Federal Institute of Technology in Zürich. He received his PhD in 1979 for a thesis with Jean-Pierre Kraehenbuhl at the University of Lausanne. After postdoctoral work in Lausanne and with Frank Ruddle at Yale University, USA, he became group leader at ISREC in 1984, was promoted senior scientist in 1988 and EPFL Adjunct Professor (professeur titulaire) in June 2008.
Pierre GönczyPierre Gönczy obtained his PhD from The Rockefeller University (New York, USA) in 1995 and joined the laboratory of Tony Hyman at the EMBL (Heidelberg, Germany) as a postdoctoral fellow in 1996. He started his own laboratory at ISREC in 2000. In 2005, he became Associate Professor at the EPFL School of Life Sciences, and was promoted Full Professor in 2009.
Dominique PiolettiDominique Pioletti received his Master in Physics from the Swiss Federal Institute of Technology Lausanne (EPFL) in 1992. He pursued his education in the same Institution and obtained his PhD in biomechanics in 1997. He developed original constitutive laws taking into account viscoelasticity in large deformations. Then he spent two years at UCSD as post-doc fellow acquiring know-how in cell and molecular biology. He was interested in particular to gene expression of bone cells in contact to orthopedic implant. In April 2006, Dominique Pioletti was appointed Assistant Professor tenure-track at the EPFL and is director of the Laboratory of Biomechanical Orthopedics. His research topics include biomechanics and tissue engineering of musculo-skeletal tissues; mechano-transduction in bone; development of orthopedic implant as drug delivery system. Since 2013, he has been promoted to the rank of Associate Professor.
Daniel ThalmannProf. Daniel Thalmann is Honorary Professor at EPFL and Director of Research development at MIRALab Sarl. He has been Visiting Professor at The Institute for Media Innovation (Nanyang Technological University, Singapore) from 2009 to 2017. He is a pioneer in research on Virtual Humans. His current research interests include Real-time Virtual Humans in Virtual Reality, crowd simulation, and 3D Interaction. Daniel Thalmann has been the Founder of The Virtual Reality Lab (VRlab) at EPFL, Switzerland, Professor at The University of Montreal and Visiting Professor/ Researcher at CERN, University of Nebraska, University of Tokyo, and National University of Singapore. Until October 2010, he was the President of the Swiss Association of Research in Information Technology and one Director of the European Research Consortium in Informatics and Mathematics (ERCIM). He is coeditor-in-chief of the Journal of Computer Animation and Virtual Worlds, and member of the editorial board of 6 other journals. Daniel Thalmann was member of numerous Program Committees, Program Chair and CoChair of several conferences including IEEE VR, ACM VRST, and ACM VRCAI. Daniel Thalmann has published more than 500 papers in Graphics, Animation, and Virtual Reality. He is coeditor of 30 books, and coauthor of several books including 'Crowd Simulation' (second edition 2012) and 'Stepping Into Virtual Reality' (2007), published by Springer. He received his PhD in Computer Science in 1977 from the University of Geneva and an Honorary Doctorate (Honoris Causa) from University Paul- Sabatier in Toulouse, France, in 2003. He also received the Eurographics Distinguished Career Award in 2010 and the 2012 Canadian Human Computer Communications Society Achievement Award. Wikipedia: http://en.wikipedia.org/wiki/Daniel_Thalmann 